This is not the most recent version of the article. View current version (14 DEC 2015)

Intervention Protocol

You have free access to this content

Different treatment regimens for magnesium sulphate for tocolysis in women in preterm labour for improving health outcomes

  1. Helen C McNamara1,*,
  2. Julie Brown2,
  3. Caroline A Crowther2,3

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 7 JUL 2014

DOI: 10.1002/14651858.CD011200


How to Cite

McNamara HC, Brown J, Crowther CA. Different treatment regimens for magnesium sulphate for tocolysis in women in preterm labour for improving health outcomes (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD011200. DOI: 10.1002/14651858.CD011200.

Author Information

  1. 1

    The Royal Women's Hospital, Parkville, Victoria, Australia

  2. 2

    The University of Auckland, Liggins Institute, Auckland, New Zealand

  3. 3

    The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Research Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia

*Helen C McNamara, The Royal Women's Hospital, 20 Flemington Road, Parkville, Victoria, 3052, Australia. helenmcnamara1@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 JUL 2014

SEARCH

This is not the most recent version of the article. View current version (14 DEC 2015)

References

Additional references

Abarbanel 1945
  • Abarbanel, AR. The spasmolysant action of magnesium ions on the tetanically contracting human gravid uterus. American Journal of Obstetrics and Gynecology 1945;49(4):473-83.
ACOG 2012
  • ACOG. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 127, June 2012. Management of preterm labor. Obstetrics and Gynecology 2012; Vol. 119:1308-17.
Bain 2012
Bain 2013
  • Bain ES, Middleton PF, Crowther CA. Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review. BMC Pregnancy and Childbirth 2013;13(1):195.
Beck 2010
  • Beck S, Wojdyla D, Say L, Betran AP, Merialdi M, Requejo JH, et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bulletin of the World Health Organization 2010;88(1):31-8.
Borna 2007
Borna 2008
Crowther 2002
  • Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD001060]
Dowling 2012
  • Dowling O, Chatterjee PK, Gupta M, Tam Tam HB, Xue X, Lewis D, et al. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. Placenta 2012;33(5):392-8.
Doyle 2009
  • Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD004661.pub3]
Duley 2010a
Duley 2010b
  • Duley LJ, Henderson-Smart D, Chou D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD000128.pub2]
Duley 2010c
Duley 2010d
  • Duley L, Matar HE, Almerie MQ, Hall DR. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database of Systematic Reviews 2010, Issue 8. [DOI: 10.1002/14651858.CD007388.pub2]
FDA 2013
  • FDA, U.S. Food, Drug Administration. FDA Recommends against prolonged use of magnesium sulfate to stop pre-term labour due to bone changes in exposed babies. Drug Safety Communications, U.S. Food and Drug Administration 2013.
Gates 2004
Glock 1993
  • Glock JL, Morales WJ. Efficacy and safety of nifedipine versus magnesium sulfate in the management of preterm labor: a randomized study. American Journal of Obstetrics and Gynecology 1993;169(4):960-4.
Goldenberg 2008
Grimes 2006
Haas 2012
Haghighi 1999
Hall 1957
Han 2013
Higgins 2011
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
How 2006
  • How HY, Zafaranchi L, Stella CL, Recht K, Maxwell RA, Sibai B, et al. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study. American Journal of Obstetrics and Gynecology 2006;194(4):976-81.
James 2010
King 2003
  • King JF, Flenady V, Papatsonis D, Dekker G, Carbonne B. Calcium channel blockers for inhibiting preterm labour. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD002255]
Klauser 2012
  • Klauser CK, Briery CM, Keiser SD, Martin RW, Kosek MA, Morrison JC. Effect of antenatal tocolysis on neonatal outcomes. Journal of Maternal Fetal & Neonatal Medicine 2012;25(12):2778-81.
Larmon 1999
  • Larmon JE, Ross BS, May WL, Dickerson GA, Fischer RG, Morrison JC. Oral nicardipine versus intravenous magnesium sulfate for the treatment of preterm labor. American Journal of Obstetrics and Gynecology 1999;181(6):1432-7.
Lewis 2005
Lurie 2004
  • Lurie S, Gur D, Sadan O, Glezerman M. Relationship between uterine contractions and serum magnesium levels in patients treated for threatened preterm labour with intravenous magnesium sulphate. Journal of Obstetrics and Gynaecology 2004;24(3):247-8.
Lyell 2007
  • Lyell DJ, Pullen K, Campbell L, Ching S, Druzin ML, Chitkara U, et al. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial. Obstetrics and Gynecology 2007;110(1):61-7.
McWhorter 2004
  • McWhorter J, Carlan SJ, O'Leary TD, Richichi K, O'Brien WF. Rofecoxib versus magnesium sulfate to arrest preterm labor: a randomized trial. Obstetrics and Gynecology 2004;103(5 Pt 1):923-30.
Mittendorf 1997
Morales 1993
  • Morales WJ, Madhav H. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: a randomized study. American Journal of Obstetrics and Gynecology 1993;169(1):97-102.
Nassar 2006
Neilson 2014
Papatsonis 2005
Pryde 2009
RevMan 2014
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Schorr 1997
  • Schorr SJ. Ketorolac is a safe and effective drug for acute tocolysis. Acta Diabetologica Latina 1997;176:S7-S7.
Steer 1977
Tam Tam 2011
  • Tam Tam HB, Dowling O, Xue X, Lewis D, Rochelson B, Metz CN. Magnesium sulfate ameliorates maternal and fetal inflammation in a rat model of maternal infection. American Journal of Obstetrics and Gynecology 2011;204(4):364.e1-364.e8.
Tsatsaris 2004
WHO 1992
  • World Health Organization. Pregnancy, childbirth and the puerperium. http://www.who.int/classifications/icd/en/ [accessed 24 May 2011] 1992.